23:48:58 EDT Tue 20 Oct 2026
Enter Symbol
or Name
USA
CA



Seegnal Inc
Symbol SEGN
Shares Issued 46,805,531
Close 2026-10-09 C$ 0.20
Market Cap C$ 9,361,106
Recent Sedar+ Documents

Seegnal completes installation within Israeli division

2026-10-20 20:05 ET - News Release

Mr. Elad Bibi-Aviv reports

SEEGNAL COMPLETES INITIAL INSTALLATION WITHIN ISRAEL'S MINISTRY OF HEALTH, MARKING MAJOR OPERATIONAL MILESTONE

Seegnal Inc. has completed an initial installation within the Israeli Ministry of Health's Government Medical Centers Division, marking a major execution milestone under the ministry-led medication decision support system project for government medical centres.

The installation advances a phased program intended to support safer, more personalized medication decisions across Israel's government medical centre network. Ness Technologies is serving as the prime contractor for the project, with Seegnal providing its medication decision support technology and related services as a subcontractor.

The ministry's tender framework provides a pathway for phased deployment across multiple general hospitals, with the potential to extend to additional psychiatric and geriatric centres. The initial installation marks the first operational milestone under that framework. The timing, scope and locations of additional deployments remain subject to ministry decisions, approved work orders and the completion of applicable implementation milestones.

Seegnal's platform integrates patient-specific clinical information, including current medications, laboratory results, renal function, allergies, age and other relevant risk factors, to deliver context-aware medication guidance at the point of care. The platform is designed to identify clinically significant medication risks while reducing less relevant alerts that can contribute to alert fatigue.

"Completing the initial installation with the Ministry of Health is a significant milestone for Seegnal and reflects our team's continued execution," said Elad Bibi-Aviv, chief executive officer of Seegnal. "This project expands our presence within large, complex health care environments and supports the program's next stages. We are proud to work alongside Ness and the ministry in advancing patient-specific medication intelligence across Israel's government medical centre network."

With the initial ministry installation complete, Seegnal and its project partners will proceed with the program's next implementation stages. Further deployments remain subject to technical integration, acceptance testing, ministry work orders and other project requirements. The company intends to provide updates as additional material milestones are achieved.

About Seegnal Inc.

Seegnal is an innovative health care technology company dedicated to reducing medication-related harm where care begins. The company's software-as-a-service-based clinical decision support platform is designed to help clinicians prescribe with greater precision by integrating patient-specific data at the point of care, including medications, laboratory results, renal function, allergies, age and other relevant risk factors. By delivering more targeted, context-aware medication alerts within existing clinical workflows, Seegnal aims to reduce alert fatigue, support safer prescribing and advance a more personalized standard of patient care. Seegnal's technology is deployed across health care settings and is used by approximately 15,000 clinicians in daily practice.

We seek Safe Harbor.

© 2026 Canjex Publishing Ltd. All rights reserved.